Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

231
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
231
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

422
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in advising people with severe mental illness to quit smoking: A conversation analysis of patient resistance.

Patient education and counseling·2026
Same author

Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).

Diabetes, obesity & metabolism·2026
Same author

In-bedroom renewed air as anti-inflammatory adjuvant therapy in cancer survivors: protocol for the randomised, placebo-controlled BREATHS N-of-1 trial series.

BMJ open·2026
Same author

Burden and economic impact of RSV hospitalisations among English adults, 2023/24.

The Journal of infection·2026
Same author

Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map.

Addiction (Abingdon, England)·2026
Same author

Reduced-nicotine cigarettes for smoking cessation and reduction.

The Cochrane database of systematic reviews·2026

Related Experiment Video

Updated: Jan 18, 2026

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.8K

Smoking reduction interventions for smoking cessation.

Nicola Lindson1, Elias Klemperer, Bosun Hong

  • 1Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, Oxfordshire, UK, OX2 6GG.

The Cochrane Database of Systematic Reviews
|October 1, 2019
PubMed
Summary

Reducing smoking before quitting (reduction-to-quit) is as effective as abrupt quitting. Combining reduction strategies with varenicline or fast-acting nicotine replacement therapy (NRT) may improve cessation rates. Further research is needed to optimize these methods.

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.8K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.8K
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.8K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.5K

Area of Science:

  • Public Health
  • Addiction Medicine
  • Behavioral Science

Background:

  • Standard smoking cessation advice often emphasizes abrupt quitting on a set date.
  • Individuals attempting to quit smoking may seek alternative methods beyond abrupt cessation.
  • Reducing smoking behavior prior to quitting is a potential alternative cessation strategy.

Purpose of the Study:

  • To evaluate the effectiveness of reduction-to-quit interventions for long-term smoking cessation.
  • To compare reduction-to-quit strategies against abrupt quitting and no treatment interventions.
  • To identify factors that may optimize reduction-to-quit methods for enhanced success rates.

Main Methods:

  • Systematic review and meta-analysis of 51 randomized controlled trials (RCTs) involving 22,509 participants.
  • Studies compared reduction-to-quit interventions with no treatment, abrupt quitting, or other reduction strategies.
  • Long-term smoking cessation was assessed at a minimum of six months follow-up.

Main Results:

  • Reduction-to-quit interventions showed no significant difference in long-term quit rates compared to abrupt quitting (moderate certainty evidence).
  • Evidence comparing reduction-to-quit to no treatment was inconclusive (low certainty).
  • Pharmacotherapy, particularly varenicline or fast-acting nicotine replacement therapy (NRT), appeared to enhance quit rates when used with reduction strategies (moderate certainty).

Conclusions:

  • Neither reduction-to-quit nor abrupt quitting strategies demonstrate superior long-term smoking cessation rates.
  • Pharmacotherapy-assisted reduction-to-quit interventions show promise, especially with varenicline or fast-acting NRT.
  • Further high-quality research is recommended to isolate the effects of reduction strategies and optimize their implementation.